Methylsulfonylmethane / Catalase Cancer Research Results

MSM, Methylsulfonylmethane: Click to Expand ⟱
Features:
MSM (Methylsulfonylmethane) is a naturally occurring organosulfur compound often used as a dietary supplement for its anti-inflammatory and antioxidant effects. While most well-known for joint health.
-MSM is actually a metabolite of DMSO (dimethyl sulfoxide)
-Generally Recognized as Safe     Possible Interactions: aspirin, warfarin, NSAIDS
-Supplement dosage: 500mg 2-3times/day
-Anti-inflammatory: ↓NF-κB, ↓COX-2 and iNOS -↓STAT3 -↓Cyclin D1 and CDK4, halting cell cycle progression. -↓MMP-2, MMP-9, VEGF limiting invasion.

Methylsulfonylmethane (MSM) — Cancer-Oriented Time-Scale Flagged Pathway Table
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 NF-κB inflammatory transcription NF-κB ↓; COX-2/cytokines ↓ (reported) Inflammation tone ↓ R, G Anti-inflammatory signaling One of the most consistent findings in MSM studies is suppression of NF-κB-linked inflammatory signaling.
2 STAT3 signaling STAT3 phosphorylation ↓ (reported) R, G Pro-survival pathway suppression STAT3 inhibition has been reported in some breast and other tumor models; relevance depends on tumor type.
3 PI3K / AKT pathway AKT signaling ↓ (reported; model-dependent) R, G Growth modulation Observed in certain cell lines; should be presented as context-dependent rather than universal.
4 ROS / redox modulation ROS ↓ (often); oxidative stress tone ↓ Oxidative injury ↓ P, R, G Redox buffering MSM is generally described as anti-oxidative/anti-inflammatory rather than pro-oxidant; not a ROS-amplifying therapy.
5 Apoptosis induction Caspases ↑; Bax ↑; Bcl-2 ↓ (reported) G Cell death signaling Apoptotic effects reported in vitro; usually downstream of inflammatory and survival pathway suppression.
6 Cell-cycle regulation Cell-cycle arrest ↑ (reported) G Cytostasis Observed in some cancer cell systems; mechanism linked to signaling changes.
7 Migration / invasion (MMPs) MMP expression ↓; migration ↓ (reported) G Anti-invasive phenotype Reduction in metastasis markers reported in certain preclinical models.
8 ER stress modulation Stress signaling modulation (context-dependent) Proteostasis support R, G Stress pathway modulation Less consistent than NF-κB effects; should be kept qualified.
9 Chemo-/radiation interaction (theoretical) May reduce inflammatory toxicity; may blunt ROS-based therapies Normal tissue protection possible G Adjunct positioning Because MSM is anti-oxidative/anti-inflammatory, positioning with strong pro-oxidant therapies should be considered carefully.
10 Translation constraint Human anti-cancer efficacy not established Generally well tolerated in common supplement ranges Evidence limitation Evidence base is largely preclinical; clinical oncology data are limited.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (NF-κB / STAT3 pathway modulation)
  • G: >3 hr (cell-cycle, apoptosis, invasion phenotype changes)


For Alzheimer's (AD):
Methylsulfonylmethane (MSM) in neurobiology is primarily framed as an anti-inflammatory and redox-buffering molecule, not a direct amyloid-clearing or tau-targeting drug. Evidence is largely preclinical (cell + animal models). Position it as a neuroinflammation and oxidative stress modulator.
-Anti-inflammatory: ↓TNF-α, IL-1β, IL-6 
-↓ROS, ↑GSH, ↓NO
-may reduce Aβ plaque burden and tau hyperphosphorylation indirectly
-improves memory in rodents

Methylsulfonylmethane (MSM) — Alzheimer’s Disease (AD) Time-Scale Flagged Pathway Table
Rank Pathway / Axis AD / Brain Context TSF Primary Effect Notes / Interpretation
1 Neuroinflammation (NF-κB / cytokine signaling) Microglial activation ↓; IL-1β/TNF-α ↓ (reported) R, G Anti-inflammatory modulation MSM’s most consistent neuro-relevant signal is suppression of NF-κB-driven inflammatory tone, which is implicated in AD progression.
2 Oxidative stress / redox buffering Lipid peroxidation ↓; ROS tone ↓ (reported) R, G Neuroprotection (stress buffering) MSM is generally described as antioxidant/anti-inflammatory rather than pro-oxidant; may help mitigate oxidative injury.
3 Mitochondrial function support Mitochondrial stress ↓ (context-dependent) R, G Bioenergetic stabilization Indirect support through reduced oxidative and inflammatory burden; not a primary mitochondrial activator.
4 ER stress / proteostasis modulation UPR signaling ↓ (reported in stress models) R, G Proteostasis buffering ER stress is relevant in AD pathology; MSM may attenuate stress signaling in some models.
5 Calcium homeostasis modulation Excitotoxic stress ↓ (indirect) P, R Signal stabilization Primarily indirect via inflammatory and oxidative stress reduction.
6 Aβ pathology (direct evidence) Limited direct evidence of amyloid reduction G Indirect modulation If effects occur, they are likely secondary to reduced oxidative stress and inflammation rather than direct amyloid targeting.
7 Tau phosphorylation Limited direct mechanistic evidence G Indirect modulation No strong mechanistic evidence that MSM directly modulates tau kinases; effects likely indirect.
8 Blood–brain barrier (BBB) considerations CNS exposure plausible but not strongly quantified R PK consideration Systemic exposure is good; CNS-specific pharmacokinetics are less clearly defined.
9 Cognitive outcome evidence Limited direct human AD trial data Translation constraint Evidence base is largely mechanistic/preclinical; clinical AD efficacy not established.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (microglial signaling + oxidative stress modulation)
  • G: >3 hr (phenotype-level neuroprotection effects)


Catalase, Catalase: Click to Expand ⟱
Source:
Type:
Caspases are a cysteine protease that speed up a chemical reaction via pointing their target substrates following an aspartic acid residue.1 They are grouped into apoptotic (caspase-2, 3, 6, 7, 8, 9 and 10) and inflammatory (caspase-1, 4, 5, 11 and 12) mediated caspases.
Caspase-1 may have both tumorigenic or antitumorigenic effects on cancer development and progression, but it depends on the type of inflammasome, methodology, and cancer.
Catalase is an enzyme found in nearly all living cells exposed to oxygen. Its primary role is to protect cells from oxidative damage by catalyzing the conversion of hydrogen peroxide (H₂O₂), a potentially damaging byproduct of metabolism, into water (H₂O) and oxygen (O₂). This detoxification process is crucial because excess H₂O₂ can lead to the formation of reactive oxygen species (ROS) that damage proteins, lipids, and DNA.

Catalase and Cancer
Oxidative Stress and Cancer:
Cancer cells often experience increased levels of oxidative stress due to rapid proliferation and metabolic changes. This stress can lead to DNA damage, promoting tumorigenesis.
Catalase helps mitigate oxidative stress, and its expression can influence the survival and proliferation of cancer cells.
Expression Levels in Different Cancers:
Overexpression: In some cancers, such as breast cancer and certain types of leukemia, catalase may be overexpressed. This overexpression can help cancer cells survive in oxidative environments, potentially leading to more aggressive tumor behavior.
Downregulation: Conversely, in other cancers, such as colorectal cancer, reduced catalase expression has been observed. This downregulation can lead to increased oxidative stress, contributing to tumor progression and metastasis.
Prognostic Implications:
Survival Rates: Studies have shown that high levels of catalase expression can be associated with poor prognosis in certain cancers, as it may enable cancer cells to resist apoptosis (programmed cell death) induced by oxidative stress.

Some types of cancer cells have been reported to exhibit lower catalase activity, possibly increasing their vulnerability to oxidative damage under certain conditions. This vulnerability has even been exploited in some therapeutic strategies (for example, approaches that generate excess H₂O₂ or other ROS specifically targeting cancer cells have been researched).


Scientific Papers found: Click to Expand⟱
3848- MSM,    Modulatory effect of methylsulfonylmethane against BPA/γ-radiation induced neurodegenerative alterations in rats: Influence of TREM-2/DAP-12/Syk pathway
- in-vitro, AD, NA
*ROS↓, *Inflam↓, *neuroP↑, *ER(estro)↑, *NRF2↑, *HO-1↑, *Trx1↑, *TXNIP↓, *MDA↓, *NOX↓, *GSH↑, *GPx↑, *SOD↑, *Catalase↑, *BDNF↑, *AChE↓, *p‑tau↓, *Aβ↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

Catalase↑, 1,   GPx↑, 1,   GSH↑, 1,   HO-1↑, 1,   MDA↓, 1,   NRF2↑, 1,   ROS↓, 1,   SOD↑, 1,   Trx1↑, 1,  

Migration

TXNIP↓, 1,  

Immune & Inflammatory Signaling

Inflam↓, 1,  

Cellular Microenvironment

NOX↓, 1,  

Synaptic & Neurotransmission

AChE↓, 1,   BDNF↑, 1,   p‑tau↓, 1,  

Protein Aggregation

Aβ↓, 1,  

Hormonal & Nuclear Receptors

ER(estro)↑, 1,  

Functional Outcomes

neuroP↑, 1,  
Total Targets: 18

Scientific Paper Hit Count for: Catalase, Catalase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:124  Target#:46  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page